Search

Your search keyword '"Carcinoma -- Care and treatment"' showing total 1,171 results

Search Constraints

Start Over You searched for: Descriptor "Carcinoma -- Care and treatment" Remove constraint Descriptor: "Carcinoma -- Care and treatment"
1,171 results on '"Carcinoma -- Care and treatment"'

Search Results

951. Studies from Martin-Luther University, Institute of Medical Immunology in the area of carcinoma therapy described

952. Research from Pamela Youde Nethersole Eastern Hospital, Department of Clinical Oncology yields new findings on nasopharyngeal carcinoma therapy

953. Thyroid carcinoma patients might benefit from radioiodine therapy

954. Thyroid carcinoma patients might benefit from radioiodine therapy

955. Thyroid carcinoma patients might benefit from radioiodine therapy

956. Ovarian carcinoma cells vary in sensitivity to various chemotherapy agents

957. Neuroendocrine carcinoma did not benefit from paclitaxel, carboplatin, and etoposide

958. Endometrial carcinoma favorable outcome linked to intensity-modulated radiation therapy

959. Cervical carcinoma treated by concurrent cisplatin and radiotherapy

960. Ovarian carcinoma cells vary in sensitivity to various chemotherapy agents

961. Neuroendocrine carcinoma did not benefit from paclitaxel, carboplatin, and etoposide

962. Endometrial carcinoma favorable outcome linked to intensity-modulated radiation therapy

963. Cervical carcinoma treated by concurrent cisplatin and radiotherapy

964. Ovarian carcinoma cells vary in sensitivity to various chemotherapy agents

965. Neuroendocrine carcinoma did not benefit from paclitaxel, carboplatin, and etoposide

966. Endometrial carcinoma favorable outcome linked to intensity-modulated radiation therapy

967. Cervical carcinoma treated by concurrent cisplatin and radiotherapy

968. Medullary thyroid carcinoma with liver metastases treated by chemoembolization

969. Medullary thyroid carcinoma with liver metastases treated by chemoembolization

970. Medullary thyroid carcinoma with liver metastases treated by chemoembolization

971. Penile carcinoma patient underwent successful penile preservation surgery

972. Merkel cell carcinoma evaluated and managed by sentinel lymph node biopsy

973. Penile carcinoma patient underwent successful penile preservation surgery

974. Merkel cell carcinoma evaluated and managed by sentinel lymph node biopsy

975. Penile carcinoma patient underwent successful penile preservation surgery

976. Merkel cell carcinoma evaluated and managed by sentinel lymph node biopsy

977. Epithelial ovarian carcinoma prognostic factors after positive second-look surgery identified

978. Small cell carcinoma of larynx treated by irinotecan and cisplatin

979. Small cell carcinoma of larynx treated by irinotecan and cisplatin

980. Small cell carcinoma of larynx treated by irinotecan and cisplatin

981. Carbon dioxide laser microsurgery effectively treats early glottic carcinoma

982. Nasopharyngeal carcinoma controlled with external beam radiotherapy supplemented by HDRIB

983. Adenoid cystic carcinoma of the sinonasal tract treatments are reviewed

984. Nasopharyngeal carcinoma controlled with external beam radiotherapy supplemented by HDRIB

985. Adenoid cystic carcinoma of the sinonasal tract treatments are reviewed

986. Nasopharyngeal carcinoma controlled with external beam radiotherapy supplemented by HDRIB

987. Adenoid cystic carcinoma of the sinonasal tract treatments are reviewed

988. Differentiated thyroid carcinoma surgical treatment options reviewed

989. Oropharyngeal carcinoma patient quality of life influenced by gender

990. Differentiated thyroid carcinoma surgical treatment options reviewed

991. Oropharyngeal carcinoma patient quality of life influenced by gender

992. Differentiated thyroid carcinoma surgical treatment options reviewed

993. Oropharyngeal carcinoma patient quality of life influenced by gender

994. Neck of patients with laryngeal carcinoma treated by elective lateral neck dissection

995. Neck of patients with laryngeal carcinoma treated by elective lateral neck dissection

996. Neck of patients with laryngeal carcinoma treated by elective lateral neck dissection

997. Dissection of submandibular gland in laryngeal and/or hypopharyngeal carcinoma patients not advised

998. Dissection of submandibular gland in laryngeal and/or hypopharyngeal carcinoma patients not advised

999. Dissection of submandibular gland in laryngeal and/or hypopharyngeal carcinoma patients not advised

1000. Nasopharyngeal carcinoma treated by stereotactic radiosurgery plus intracavitary irradiation

Catalog

Books, media, physical & digital resources